Phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) and ionomycin (500 ng/ml) were used for restimulation of less than 6 hours. PMA (1 ng/ml) and ionomycin (500 ng/ml) were used for restimulation of greater than 12 hours. BALB/c Stat4 Ϫ/Ϫ (12), C57BL/6 Ifng ϩ/Ϫ (17) , and wild-type mice were obtained from the Jackson Laboratories. C57BL/6 Cbp ϩ/Ϫ mice were generated as described (26) . All animal work was performed in accordance with University of Pennsylvania guidelines.
For retroviral transduction, polymerase chain reaction (PCR) was used to add a consensus Kozak sequence upstream of the T-bet start ATG, and the cDNA was cloned into vector MigRI upstream of an internal ribosomal entry sequence followed by GFP cDNA. Transfection of a packaging cell line was performed as described (17) . CD8-depleted splenocytes were stimulated in the presence of mAb against CD3 (0.4 g/ml), mAb against CD28 (0.5 g/ml), rIL-2 (20 U/ml), and additional cytokines as specified. After 24 hours, cells were harvested, resuspended in viral supernatant containing polybrene (8 g/ml), and centrifuged at 6000g for 90 min at 25°C. After centrifugation, cells were resuspended in media containing rIL-2 (40 U/ml) and their initial cytokine conditions.
For DNase I hypersensitivity analysis, Stat4
Ϫ/Ϫ cells were stimulated in rIL-4 and infected with T-bet or control retrovirus. GFP-positive cells were sorted using a MoFlo cytometer (Cytomation) 2 days after infection. DNase I digestions were performed on isolated nuclei, as described (17) . Briefly, nuclei were incubated for 15 min at 37°C with DNase I (0, 0.25, or 0.5 g/ml) at a density of 4 ϫ 10 7 nuclei/ml. Analysis of the IFN-␥ locus was performed as described (21) . Briefly, genomic DNA was digested overnight with Bam HI and resolved through 0.8% agarose before transfer to nylon membranes. Blots The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxyl-terminal NES. Serine-15-phosphorylated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damageinduced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.
The gene encoding p53 mediates a major tumor suppression pathway that is frequently altered in human cancers (1) . p53 is inhibited during normal cell growth by MDM2, a proto-oncogene discovered by its genomic amplification on a murine double minute chromosome, through either ubiquitin-dependent p53 degradation in the cytoplasm (2) or repression of p53's transcriptional activity in the nucleus (3, 4) . p53 is activated after DNA damage through p53 phosphorylation (5, 6) , or in response to oncogenic insults by the activation of ARF, a tumor suppressor encoded by the alternative reading frame of the INK4a locus that is frequently altered in human cancers (7). Blocking p53 nuclear export leads to p53 stabilization and activation (8, 9) , and ARF stabilizes p53, in part, by blocking the nuclear export of both p53 and MDM2 (10, 11) , underscoring the importance of nuclear export in regulating p53 stability. The mechanism governing p53 nuclear export remains unclear, and three competing models have been proposed (12) . MDM2 may bind p53 in the nucleus and shuttle it to the cytoplasm (8, 13) , p53 may use a COOHterminal-located nuclear export signal (NES) to mediate its own nuclear export (14) , or MDM2 could ubiquitinate p53 in the nucleus to promote its nuclear export (15, 16) . To clarify the role of MDM2 in p53 nuclear export and discriminate between these models, we first examined the sensitivity to MDM2-mediated degradation and nuclear export of p53 harboring either L14Q/F19S (Leu 14 3 Gln; Phe 19 3 Ser) or L22Q/W23S (Leu 22 3 Gln; Trp 23 3 Ser) mutations (17) . Consistent with previous reports (2), both p53 L14Q/F19S and p53 L22Q/W23S were resistant to degradation by HDM2 (human homolog of MDM2) (Fig. 1A) . The inhibition of HDM2-mediated p53 degradation by these mutations could not be attributed to the loss of p53 transcriptional activity, because a mutation in the sequence-specific DNA binding domain, R273H (Arg 273 3 His), which also abolishes p53 transcriptional activity, had no detectable effect on p53 stability (18) . Despite containing the intact NES in the COOHterminal region (14) , both p53 L14Q/F19S and p53 L22Q/W23S exhibited substantially decreased nuclear export activity, from 73% with wild-type (WT) p53 to 23% and 15%, with the two mutants, respectively (Fig. 1 , B and C). The transcriptionally inactive p53
R273H was exported at an efficiency indistinguishable from that of WT p53 (Fig. 1B) . Thus, the COOH-terminal-located NES was required, but was not sufficient, for p53 nuclear export. This result is different from a previous report of normal nuclear export of a p53 L22Q/W23S -green fluorescent protein (GFP) fusion (14) . Several experimental differences in that study could have contributed to the discrepancy. These include the following, a four times longer cell fusion period, which would result in prolonged protein export; the electroporation of 10 times more plasmid DNA, which would result in a higher level of p53 protein; and the attachment of a GFP moiety that might have increased cytoplasmic retention of p53 L22Q/W23S -GFP, which would have then entered the mouse nuclei in the heterokaryons and scored as positive nuclear export. Supporting the idea that the inhibitory effect of the L22Q/W23S mutation on p53 export may be reduced or even masked by the overproduction of p53, endogenous p53 L22Q/W23S protein produced by a knock-in strategy that was expressed at a lower level is more completely blocked from nuclear export and accumulates to very high levels in the nucleus [(19), Web fig. 1 (20) ], providing in vivo evidence for the disruption of p53 nuclear export by L22Q/W23S mutations.
Blockage of p53 nuclear export by the L14Q/F19S and the L22Q/W23S mutations could be attributed to the disruption of p53-MDM2 association if MDM2 shuttled p53 out of the nucleus (10) or if MDM2 was required for p53 nuclear ubiquitination and its subsequent export (15, 16) . Alternatively, it could be attributed to an intrinsic property of the NH 2 -terminal domain of p53. We carried out a series of heterokaryon assays to determine if p53 nuclear export was dependent on MDM2. After examining a large number of heterokaryons, we did not observe apparent differences in p53 nuclear export efficiency in the absence of HDM2 or in the presence of high levels of HDM2 [Web fig. 2 (20) ]. To exclude the possibility that mouse embryo fibroblasts (MEFs) and promoted p53 export, we performed a similar heterokaryon assay in which p53 Ϫ/Ϫ -MDM2 Ϫ/Ϫ MEFs were first infected with p53-expressing adenoviruses and then fused with Saos-2 cells that had been infected with ARF-expressing adenoviruses to block MDM2 export (10, 11) . In these experiments, p53 shuttled from p53
Ϫ/Ϫ MEFs to ARF-overexpressing Saos-2 cells in a majority (76%) of the heterokaryons examined (Fig. 2, A and C) . In a separate experiment, p53 was expressed in one set of p53 Ϫ/Ϫ -MDM2 Ϫ/Ϫ MEFs, and then fused with another set of p53
Ϫ/Ϫ MEFs that had been infected with adenovirus expressing hARF (Ad-hARF) and identified by an antibody specific to human, but not mouse, ARF. In a majority (84%) of the heterokaryons formed by fusion of ARF-negative (Ad-p53 infected) and ARF-positive (uninfected) p53
Ϫ/Ϫ -MDM2 Ϫ/Ϫ MEFs, active p53 nuclear export was observed (Fig. 2, B and C) . The efficiency of p53 nuclear-cytoplasmic shuttling between two murine nuclei through the murine cytoplasm is comparable to that seen between human and mouse nuclei through a mixed human/mouse cytoplasm. Thus, p53 nuclear export was not dependent on the presence of MDM2, and impaired p53 nuclear export by the L14Q/F19S and L22Q/W23S mutations is probably caused by a mechanism other than the disruption of p53-MDM2 association. The ability of p53 to export independently of MDM2 does not exclude the possibility that p53 nuclear export may be affected by the function of MDM2.
The NH 2 -terminal region of p53 contains two hydrophobic, leucine-rich stretches that resemble the chromosomal region maintenance 1 (CRM1)-dependent NESs found in several different proteins including MDM2 and p53 (Fig. 3A) . The first leucine-rich stretch is highly conserved between human and mouse p53 (15 out of 17 residues are identical) whereas only 8 out of 18 residues in the second leucine-rich sequence are conserved. Notably, the L14Q/F19S and L22Q/ W23S mutations each alter a highly conserved hydrophobic Leu residue shown to be critically important for NES function in cyclic adenosine 3Ј, 5Ј-monophosphate (cAMP)-dependent protein kinase inhibitor (PKI) (21), HDM2 (8) , and p53 (14) . We attached both p53 [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] and p53 [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] peptides to GFP and determined whether these leucine-rich motifs function as an autonomous NES. GFP distributes throughout both the nucleus and the cytosol, with slightly more accumulation in the nucleus (Fig. 3, B and C) . Fusion of GFP with the NES from either HDM2 or the p53 COOH-terminus ( p53 cNES ) resulted in evident nuclear exclusion of fluorescence in about two-thirds of the cells (Fig. 3, B and C) , confirming the nuclear export activity of both NESs. Attachment of the peptide from p53 residues 11 to 27 ( p53 nNES ) to GFP generated clear nuclear exclusion of GFP in about two-thirds of the cells, an efficiency comparable with that of NESs from HDM2 and the p53 COOH-terminus. The nuclear exclusion of GFP by fusion with all three NESs is, however, incomplete, and nuclear fluorescence remains visible. This is probably due to the combination of weak NES activity [see Web fig. 3 for quantitative comparison (20) ] and visualization of cells as a plane, as opposed to three-dimensionally, with the consequent inability to exclude cytoplasmic fluorescence surrounding the nucleus as nonnuclear signals. Fusion with the p53 [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] peptide only weakly affected GFP distribution, and less than one-quarter of the GFPpositive cells exhibited a slight cytoplasmic accumulation of GFP. The significance of this weak nuclear export activity, if genuine, is difficult to assess and remains unclear at present. Inhibition of CRM1 by leptomycin B treatment reverted the nuclear exclusion of GFP fused with HDM2 NES , p53 cNES , and p53 nNES to that of GFP alone (Fig. 3 , B and C), indicating that nuclear export by these three NESs was CRM1-dependent. L14Q/ F19S and L22Q/W23S mutations prevented nuclear exclusion of p53 nNES -GFP, reinforcing the functional importance of these hydrophobic residues and the authenticity of the p53 nNES. The nuclear export activity of the p53 nNES , as well as that of the p53 cNES and the PKI NES , was not detectably affected by the high level of ARF expression (Fig. 3D) . Thus, the NH 2 -terminal domain of p53 appears to contain an autonomous NES that functions through the CRM1-dependent nuclear export pathway and is not dependent on MDM2.
The NH 2 -terminal p53 NES contains two serine residues, Ser 15 and Ser 20 with aspartic acid residues, which often mimic the charge of a phosphorylated serine, decreased nuclear export activity, as judged by the lack of visible nuclear exclusion of fused GFP and an increase in the ratio of nuclear to cytoplasmic fluorescence (Fig.  4A) . To directly test the idea that phosphorylation at Ser 15 and Ser 20 in p53 might impair the activity of the NH 2 -terminal NES, we determined nucleo-cytoplasmic shuttling of phosphorylated p53 induced by DNA damage. Ad-p53-infected U-2OS cells were either left untreated or exposed to ultraviolet (UV) irradiation and then fused with Ad-ARF-infected Saos-2 cells. U-2OS/Saos-2 heterokaryons were identified by immunostaining with a mouse antibody to ARF. Nucleo-cytoplasmic shuttling of total or Ser 15 -phosphorylated p53 was determined by using either a goat antibody against full-length human p53 (anti-full-length p53) or a rabbit antibody raised against a synthetic phosphoSer 15 p53 peptide (Fig. 4B) . Anti-full-length p53 antibody detected high levels of p53 in almost all U-2OS cells (ARF negative) and lower amounts in the Saos-2 cells (ARF positive) present in the heterokaryons, but not in unfused Saos-2 cells, confirming the expression of p53 in U-2OS cells and its shuttling to the recipient Saos-2 cells. Anti-phosphoSer 15 p53 detected a considerable amount of p53 in UV-irradiated, but not in untreated, cells or UV-treated p53 Ϫ/Ϫ MEFs, confirming the specificity of the antibody in recognizing only the phosphorylated form of p53. Ser 15 -phosphorylated p53 was not detected in the recipient Saos-2 cells fused with UVirradiated U-2OS cells in any of more than 30 heterokaryons that we examined. To deter- mine whether endogenously expressed, Ser 15 -phosphorylated p53 is similarly blocked from export, U-2OS cells were either left untreated or irradiated with UV and then fused with Saos-2 cells. Almost no p53 was detected in untreated U-2OS cells (Fig. 4B) . After UV irradiation, there was a substantial increase in total and Ser 15 -phosphorylated p53. Ser 15 -phosphorylated p53 was localized mostly to speckles and exhibited a pattern distinct from that detected by anti-full-length p53, suggesting that phosphorylation of p53 is associated with or promotes a change of p53 subnuclear localization. Where there was active p53 nuclear export, as determined by the use of anti-full-length p53 antibody, no Ser 15 -p53 signal was detected in the recipient Saos-2 cells of more than 30 heterokaryons examined. UV irradiation similarly resulted in a substantial increase in total and Ser 15 -phosphorylated p53 in MEFs. A portion of p53 detected by anti-full-length p53 was exported reproducibly at a lower level in MEFs than in U2OS cells, possibly resulting from more efficient p53 phosphorylation (thus blocking export) and a lower efficiency of anti-human p53 in recognizing mouse protein. Consistently, Ser 15 -phosphorylated p53 was completely blocked from nuclear export in more than 50 heterokaryons examined.
Our results reveal a previously unrecognized NES in the NH 2 -terminal region of p53 that is required for the nuclear export of p53. The two separate NESs of p53 can functionally collaborate with each other and synergistically mediate protein nuclear export [Web fig. 3 (20) ]. Having two separate NESs could provide cells with greater versatility in regulating p53 export. The carboxyl-terminal p53 NES is situated within the tetramerization domain, leading to the postulation that regulated p53 tetramerization occludes this NES, thereby ensuring nuclear retention of the active DNA-binding form of p53 (14 ) . The amino terminus of p53 contains several sites whose phosphorylation by various DNA damage-activated p53 kinases leads to p53 stabilization and activation (22) . The inability of Ser 15 -phosphorylated p53 to undergo nuclear export suggests a previously unrecognised mechanism-inhibitory phosphorylation of a NES-for stabilizing and activating p53 in response to DNA damage. It remains to be determined whether phosphorylation at Ser 15 alone is sufficient to inhibit p53 export or whether simultaneous phosphorylation at multiple residues, including Ser 20 , is required. Phosphorylation at Ser 15 and Ser 20 has been suggested to cause p53 stabilization by hindering p53-MDM2 binding (24 ) . Because p53 can undergo active nuclear export in the absence of MDM2 (14 ) (Fig. 2) , inhibition of MDM2 binding, although preventing p53 degradation, would not block p53 nuclear export and thus would not efficiently accumulate p53 in the nucleus to allow maximal p53 activation. On the other hand, inhibiting p53 nuclear export without breaking its binding with MDM2, although causing the nuclear accumulation of p53, would not reach maximal p53 activation either because MDM2, in addition to its activity in promoting cytoplasmic p53 degradation, can also directly inhibit p53's transactivating activity in the nucleus (4 ). We suggest that DNA damage-induced phosphorylation may achieve optimal p53 activation through the additive and complementary action of both inhibiting MDM2 binding to, and the nuclear export of, p53.
